TW438587B
(en)
|
1995-06-20 |
2001-06-07 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
NZ286920A
(en)
*
|
1995-07-03 |
1997-06-24 |
Sankyo Co |
Use of combination of hmg-coa reductase inhibitors and of insulin sensitizers for the prevention/treatment of arteriosclerosis or xanthoma
|
EA199800177A1
(ru)
|
1995-08-10 |
1998-10-29 |
Варнер-Ламберт Компани |
Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
|
PL189066B1
(pl)
|
1996-04-05 |
2005-06-30 |
Takeda Pharmaceutical |
Kompozycja farmaceutyczna do zapobiegania lub zwalczania chorób związanych z angiotensyną II oraz stosowanie związków do wytwarzania leku do zapobiegania lub zwalczania chorób związanych z angiotensyną II
|
CA2261040C
(en)
|
1996-07-15 |
2009-01-20 |
Sankyo Company, Limited |
Pharmaceutical composition comprising combination useful for treatment or prevention of arteriosclerosis or xanthoma
|
FR2758459B1
(fr)
*
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
US6011049A
(en)
*
|
1997-02-19 |
2000-01-04 |
Warner-Lambert Company |
Combinations for diabetes
|
US5859037A
(en)
*
|
1997-02-19 |
1999-01-12 |
Warner-Lambert Company |
Sulfonylurea-glitazone combinations for diabetes
|
US6291495B1
(en)
|
1997-02-24 |
2001-09-18 |
Robert B. Rieveley |
Method and composition for the treatment of diabetes
|
AU783539B2
(en)
*
|
1997-06-18 |
2005-11-10 |
Smithkline Beecham Plc |
Treatment of diabetes with thiazolidinedione and sulphonylurea
|
EP1671637A3
(en)
*
|
1997-06-18 |
2007-12-19 |
SmithKline Beecham P.L.C. |
Treatment of diabetes with thiazolidinedione and sulphonylurea
|
US20020004515A1
(en)
*
|
1997-06-18 |
2002-01-10 |
Smith Stephen Alistair |
Treatment of diabetes with thiazolidinedione and metformin
|
US20010049380A1
(en)
*
|
1997-06-18 |
2001-12-06 |
Smith Stephen Alistair |
Treatment of diabetes with thiazolidinedione and sulphonylurea
|
US20020028768A1
(en)
*
|
1997-06-18 |
2002-03-07 |
Smithkline Beecham P.L.C. |
Treatment of diabetes with rosiglitazone and insulin
|
KR20010013845A
(ko)
*
|
1997-06-18 |
2001-02-26 |
피터 기딩스 |
티아졸리딘디온 및 알파-글루코시다제 억제제를 사용한당뇨병의 치료
|
AU778947B2
(en)
*
|
1997-06-18 |
2004-12-23 |
Smithkline Beecham Plc |
Treatment of diabetes with thiazolidinedione and metformin
|
JP2002504137A
(ja)
*
|
1997-06-18 |
2002-02-05 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
チアゾリジンジオンおよびメトホルミンを用いる糖尿病の治療
|
US20020016287A1
(en)
*
|
1997-07-18 |
2002-02-07 |
Smithkline Beecham P.L.C. |
Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
|
AU782419B2
(en)
*
|
1997-07-18 |
2005-07-28 |
Smithkline Beecham Plc |
Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
|
GB9715298D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
GB9715295D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
GB9715306D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
BR9814090A
(pt)
*
|
1997-10-20 |
2000-10-03 |
Dainippon Pharmaceutical Co |
Composição de drogas rapidamente solúvel
|
US6583157B2
(en)
|
1998-01-29 |
2003-06-24 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
JP4253126B2
(ja)
|
1998-01-29 |
2009-04-08 |
アムジェン インコーポレイテッド |
Ppar−ガンマ調節剤
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US7105552B2
(en)
|
1998-05-08 |
2006-09-12 |
Theracos, Inc. |
Heterocyclic analogs of diphenylethylene compounds
|
US6221897B1
(en)
*
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
JP2000080047A
(ja)
*
|
1998-06-30 |
2000-03-21 |
Takeda Chem Ind Ltd |
医 薬
|
DK1093370T3
(da)
*
|
1998-06-30 |
2006-05-22 |
Takeda Pharmaceutical |
Farmaceutisk præparat til behandling af diabetes
|
PT974356E
(pt)
*
|
1998-07-15 |
2004-02-27 |
Merck Sante Sas |
Comprimidos compreendendo uma combinacao de metformina e de glibenclamida
|
US6376549B1
(en)
*
|
1998-09-17 |
2002-04-23 |
Akesis Pharmaceuticals, Inc. |
Metforimin-containing compositions for the treatment of diabetes
|
PL347508A1
(en)
*
|
1998-10-29 |
2002-04-08 |
Regents Board Of |
Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation
|
US20030153607A1
(en)
*
|
1998-11-12 |
2003-08-14 |
Smithkline Beecham P.L.C. |
Novel composition and use
|
AP1692A
(en)
*
|
1998-11-12 |
2006-12-12 |
Smithkline Beecham Plc |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.
|
US20040081697A1
(en)
*
|
1998-11-12 |
2004-04-29 |
Smithkline Beecham P.L.C. |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
NZ511614A
(en)
*
|
1998-11-12 |
2003-12-19 |
Smithkline Beecham P |
Modified release pharmaceutical composition containing the insulin sensitiser 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and the antidiabetic agent metaformin
|
US20040102486A1
(en)
*
|
1998-11-12 |
2004-05-27 |
Smithkline Beecham Corporation |
Novel method of treatment
|
DZ2937A1
(fr)
*
|
1998-11-12 |
2004-03-15 |
Smithkline Beecham Plc |
Compositions nouvelles de sensibilidants à l'insuline.
|
US6958324B2
(en)
*
|
1998-12-02 |
2005-10-25 |
Inotek Pharmaceuticals Corporation |
Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
|
US20080269265A1
(en)
*
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
NZ512219A
(en)
*
|
1998-12-24 |
2004-12-24 |
Metabasis Therapeutics Inc |
A combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
|
US6756360B1
(en)
|
1998-12-24 |
2004-06-29 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
|
JP4799720B2
(ja)
*
|
1999-01-29 |
2011-10-26 |
武田薬品工業株式会社 |
コーティング処理を施した打錠用杵
|
US6787082B1
(en)
*
|
1999-01-29 |
2004-09-07 |
Takeda Chemical Industries, Ltd. |
Compressing mallet with coating treatment
|
GB0001662D0
(en)
|
1999-02-06 |
2000-03-15 |
Zeneca Ltd |
Pharmaceutical compositions
|
WO2000059855A1
(en)
*
|
1999-04-01 |
2000-10-12 |
Esperion Therapeutics, Inc. |
Ether compounds, compositions, and uses thereof
|
US7407978B2
(en)
*
|
1999-04-06 |
2008-08-05 |
Theracos, Inc. |
Heterocyclic analogs of diphenylethylene compounds
|
JP2000355550A
(ja)
*
|
1999-04-14 |
2000-12-26 |
Takeda Chem Ind Ltd |
ケトーシス改善剤
|
TWI249401B
(en)
|
1999-04-14 |
2006-02-21 |
Takeda Chemical Industries Ltd |
Agent for improving ketosis
|
CN1208335C
(zh)
*
|
1999-04-23 |
2005-06-29 |
史密丝克莱恩比彻姆有限公司 |
噻唑烷二酮衍生物及其作为抗糖尿病药的用途
|
GB9910693D0
(en)
*
|
1999-05-07 |
1999-07-07 |
Univ Liverpool |
A compound for use in medicine
|
US6214842B1
(en)
*
|
1999-05-12 |
2001-04-10 |
Michael S. Malamas |
Amino-thiazolidinediones useful in the treatment of insulin resistance and hyperglycemia
|
EP1194147B1
(en)
*
|
1999-06-18 |
2007-01-10 |
Merck & Co., Inc. |
Arylthiazolidinedione and aryloxazolidinedione derivatives
|
USRE40876E1
(en)
*
|
1999-06-21 |
2009-08-18 |
Eli Lilly And Company |
Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagonlike peptide-1 and agonists thereof
|
CA2369839A1
(en)
*
|
1999-06-25 |
2001-01-04 |
Minimed, Inc. |
Compositions of insulin and insulin-related peptide for treating diabetes
|
IL147308A0
(en)
*
|
1999-06-30 |
2002-08-14 |
Tularik Inc |
Compounds for the modulation of pparγ activity and pharmaceutical compositions containing the same
|
AU779730B2
(en)
*
|
1999-06-30 |
2005-02-10 |
Amgen, Inc. |
Compounds for the modulation of PPARgamma activity
|
US7041691B1
(en)
|
1999-06-30 |
2006-05-09 |
Amgen Inc. |
Compounds for the modulation of PPARγ activity
|
CO5200844A1
(es)
*
|
1999-09-17 |
2002-09-27 |
Novartis Ag |
Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
|
US6878749B2
(en)
|
1999-09-17 |
2005-04-12 |
Novartis Ag |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
US6559188B1
(en)
|
1999-09-17 |
2003-05-06 |
Novartis Ag |
Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
|
AU2005200818B2
(en)
*
|
1999-09-17 |
2008-07-17 |
Novartis Ag |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
CA2386379C
(en)
*
|
1999-10-06 |
2009-12-15 |
Toshio Miyata |
Carbonyl stress-decreasing agent
|
WO2001026639A2
(en)
*
|
1999-10-08 |
2001-04-19 |
Novartis Ag |
Pharmaceutical composition of ateglinide and another antidiabeticagent
|
US6274622B1
(en)
*
|
1999-10-27 |
2001-08-14 |
Frederick H. Hausheer |
Method of treating diabetic ophthalmopathy
|
US6586438B2
(en)
|
1999-11-03 |
2003-07-01 |
Bristol-Myers Squibb Co. |
Antidiabetic formulation and method
|
BR0015294A
(pt)
|
1999-11-03 |
2003-07-15 |
Bristol Myers Squibb Co |
Método para tratamento da diabetes
|
MY125516A
(en)
*
|
1999-11-16 |
2006-08-30 |
Smithkline Beecham Plc |
Novel composition based on thiazolidinedione and metformin and use
|
US6660021B1
(en)
|
1999-12-23 |
2003-12-09 |
Advanced Cardiovascular Systems, Inc. |
Intravascular device and system
|
US6575997B1
(en)
|
1999-12-23 |
2003-06-10 |
Endovascular Technologies, Inc. |
Embolic basket
|
US6402771B1
(en)
|
1999-12-23 |
2002-06-11 |
Guidant Endovascular Solutions |
Snare
|
AU2382601A
(en)
*
|
1999-12-24 |
2001-07-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
GB9930688D0
(en)
*
|
1999-12-24 |
2000-02-16 |
Smithkline Beecham Plc |
Novel method of treatment
|
US7918820B2
(en)
|
1999-12-30 |
2011-04-05 |
Advanced Cardiovascular Systems, Inc. |
Device for, and method of, blocking emboli in vessels such as blood arteries
|
US6695813B1
(en)
|
1999-12-30 |
2004-02-24 |
Advanced Cardiovascular Systems, Inc. |
Embolic protection devices
|
US20010036479A1
(en)
|
2000-01-14 |
2001-11-01 |
Gillian Cave |
Glyburide composition
|
AU2001229601A1
(en)
*
|
2000-01-24 |
2001-07-31 |
Inotek Corporation |
Method and composition for modulating an immune response
|
US6540982B1
(en)
*
|
2000-01-25 |
2003-04-01 |
Aeropharm Technology Incorporated |
Medical aerosol formulation
|
EP1254667A4
(en)
*
|
2000-02-10 |
2003-03-12 |
Takeda Chemical Industries Ltd |
MEDICINE COMPRISING A COMBINATION
|
EP1295609A4
(en)
*
|
2000-02-24 |
2004-11-03 |
Takeda Chemical Industries Ltd |
DRUGS CONTAINING COMBINED ACTIVE INGREDIENTS
|
US6296874B1
(en)
*
|
2000-05-01 |
2001-10-02 |
Aeropharm Technology Incorporated |
Core formulation comprising troglitazone and abiguanide
|
US6461639B2
(en)
|
2000-05-01 |
2002-10-08 |
Aeropharm Technology, Inc. |
Core formulation
|
US6451342B2
(en)
|
2000-05-01 |
2002-09-17 |
Aeropharm Technology Incorporated |
Core formulation comprised of troglitazone and a biguanide
|
US6524621B2
(en)
|
2000-05-01 |
2003-02-25 |
Aeropharm Technology Inc. |
Core formulation
|
US6548049B1
(en)
*
|
2000-05-01 |
2003-04-15 |
Aeropharm Technology Incorporated |
Medicinal aerosol formulation
|
US6610272B1
(en)
|
2000-05-01 |
2003-08-26 |
Aeropharm Technology Incorporated |
Medicinal aerosol formulation
|
US6653332B2
(en)
|
2000-05-03 |
2003-11-25 |
Tularik Inc. |
Combination therapeutic compositions and method of use
|
US6270797B1
(en)
*
|
2000-05-18 |
2001-08-07 |
Usv Limited |
Sustained release pharmaceutical composition containing glipizide and method for producing same
|
US6939362B2
(en)
*
|
2001-11-27 |
2005-09-06 |
Advanced Cardiovascular Systems, Inc. |
Offset proximal cage for embolic filtering devices
|
US20030171399A1
(en)
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
US7563774B2
(en)
|
2000-06-29 |
2009-07-21 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
|
US6964670B1
(en)
|
2000-07-13 |
2005-11-15 |
Advanced Cardiovascular Systems, Inc. |
Embolic protection guide wire
|
US20060089389A1
(en)
*
|
2000-08-22 |
2006-04-27 |
Malcolm Allison |
Combination
|
PE20020617A1
(es)
*
|
2000-08-22 |
2002-08-05 |
Novartis Ag |
Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
CA2424060A1
(en)
*
|
2000-10-12 |
2003-03-31 |
Nissan Chemical Industries, Ltd. |
Preventives and remedies for complications of diabetes
|
US6506203B1
(en)
|
2000-12-19 |
2003-01-14 |
Advanced Cardiovascular Systems, Inc. |
Low profile sheathless embolic protection system
|
CA2434169C
(en)
|
2001-01-12 |
2011-03-15 |
Sun Pharmaceutical Industries Limited |
Spaced drug delivery system
|
WO2002067969A2
(en)
|
2001-02-21 |
2002-09-06 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
ES2240657T3
(es)
|
2001-02-28 |
2005-10-16 |
Pfizer Products Inc. |
Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa.
|
ES2266494T3
(es)
*
|
2001-03-02 |
2007-03-01 |
Divapharma Chur Ag |
Formulacion combinado para el tratamiento de la de la diabetes mellitas.
|
KR200249057Y1
(ko)
*
|
2001-03-22 |
2001-10-19 |
김진환 |
뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
|
AU2002226634B2
(en)
*
|
2001-03-30 |
2007-01-25 |
Pfizer Products Inc. |
Pyridazinone aldose reductase inhibitors
|
JPWO2002080924A1
(ja)
*
|
2001-04-03 |
2004-07-29 |
山之内製薬株式会社 |
アリールエテンスルホンアミド誘導体の新規な用途
|
MXPA03008997A
(es)
*
|
2001-04-10 |
2004-02-12 |
Sun Pharmaceutical Ind Ltd |
Composicion de liberacion por impulso temporizado.
|
SE0101982D0
(sv)
*
|
2001-06-01 |
2001-06-01 |
Astrazeneca Ab |
Pharmaceutical combination
|
JP2002360666A
(ja)
*
|
2001-06-11 |
2002-12-17 |
Takeda Chem Ind Ltd |
コバルト合金を用いた打錠用杵臼
|
US6737401B2
(en)
*
|
2001-06-28 |
2004-05-18 |
Metronic Minimed, Inc. |
Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
|
US7338510B2
(en)
|
2001-06-29 |
2008-03-04 |
Advanced Cardiovascular Systems, Inc. |
Variable thickness embolic filtering devices and method of manufacturing the same
|
US6599307B1
(en)
|
2001-06-29 |
2003-07-29 |
Advanced Cardiovascular Systems, Inc. |
Filter device for embolic protection systems
|
EP1429732A4
(en)
*
|
2001-07-10 |
2005-01-26 |
Kos Life Sciences Inc |
CORE FORMULATION
|
JP2004536843A
(ja)
*
|
2001-07-10 |
2004-12-09 |
エアロファーム テクノロジー インコーポレイテッド |
ピオグリタゾンおよびビグアナイドを含むコア製剤
|
US6638294B1
(en)
|
2001-08-30 |
2003-10-28 |
Advanced Cardiovascular Systems, Inc. |
Self furling umbrella frame for carotid filter
|
US6592606B2
(en)
|
2001-08-31 |
2003-07-15 |
Advanced Cardiovascular Systems, Inc. |
Hinged short cage for an embolic protection device
|
US8262689B2
(en)
|
2001-09-28 |
2012-09-11 |
Advanced Cardiovascular Systems, Inc. |
Embolic filtering devices
|
WO2003048140A1
(fr)
|
2001-12-03 |
2003-06-12 |
Japan Tobacco Inc. |
Compose azole et utilisation medicinale de celui-ci
|
US7241304B2
(en)
|
2001-12-21 |
2007-07-10 |
Advanced Cardiovascular Systems, Inc. |
Flexible and conformable embolic filtering devices
|
DE10200138A1
(de)
*
|
2002-01-04 |
2003-07-17 |
Karl Winkler |
Kombination von einem PPAR-Agonisten mit PPAR-alpha Aktivität mit einem Induktor des LDL-Rezeptors
|
TWI327462B
(en)
*
|
2002-01-18 |
2010-07-21 |
Sumitomo Chemical Co |
Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
US20030187074A1
(en)
*
|
2002-03-04 |
2003-10-02 |
Javed Hussain |
Oral compositions for treatment of diabetes
|
AR039090A1
(es)
*
|
2002-03-22 |
2005-02-09 |
Novartis Ag |
Combinacion de compuestos organicos
|
WO2003091728A1
(fr)
*
|
2002-04-26 |
2003-11-06 |
Takeda Chemical Industries, Ltd. |
Methode de criblage
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
WO2003105809A1
(en)
|
2002-06-17 |
2003-12-24 |
Themis Laboratories Private Limited |
Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
|
WO2004012715A1
(en)
|
2002-08-02 |
2004-02-12 |
Penwest Pharmaceuticals Company |
Sustained release formulations of metformin
|
US7232828B2
(en)
*
|
2002-08-10 |
2007-06-19 |
Bethesda Pharmaceuticals, Inc. |
PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
|
US7959946B2
(en)
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
JP4694841B2
(ja)
|
2002-09-20 |
2011-06-08 |
アンドルックス ラボズ リミテッド ライアビリティ カンパニー |
ビグアニドおよびチアゾリジンジオン誘導体を含有する多段階製剤
|
US8084058B2
(en)
|
2002-09-20 |
2011-12-27 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US9060941B2
(en)
*
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7785627B2
(en)
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7252675B2
(en)
|
2002-09-30 |
2007-08-07 |
Advanced Cardiovascular, Inc. |
Embolic filtering devices
|
US7331973B2
(en)
|
2002-09-30 |
2008-02-19 |
Avdanced Cardiovascular Systems, Inc. |
Guide wire with embolic filtering attachment
|
UA80991C2
(en)
*
|
2002-10-07 |
2007-11-26 |
|
Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
|
US20040088000A1
(en)
|
2002-10-31 |
2004-05-06 |
Muller Paul F. |
Single-wire expandable cages for embolic filtering devices
|
DE10252666A1
(de)
*
|
2002-11-11 |
2004-08-05 |
Grünenthal GmbH |
N-Piperidyl-cyclohexan-Derivate
|
IN192749B
(hu)
*
|
2002-11-15 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
DE10261067A1
(de)
*
|
2002-12-24 |
2004-08-05 |
Nutrinova Nutrition Specialties & Food Ingredients Gmbh |
Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure
|
GEP20084540B
(en)
|
2003-01-14 |
2008-11-25 |
Arena Pharm Inc |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
US6794401B2
(en)
*
|
2003-01-17 |
2004-09-21 |
Bexel Pharmaceuticals, Inc. |
Amino acid phenoxy ethers
|
DE10302452B4
(de)
*
|
2003-01-23 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US7179941B2
(en)
|
2003-01-23 |
2007-02-20 |
Sanofi-Aventis Deutschland Gmbh |
Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
|
WO2004067001A1
(ja)
*
|
2003-01-29 |
2004-08-12 |
Takeda Pharmaceutical Company Limited |
被覆製剤の製造法
|
US7572910B2
(en)
*
|
2003-02-20 |
2009-08-11 |
Pfizer, Inc. |
Pyridazinone aldose reductase inhibitors
|
US8591540B2
(en)
|
2003-02-27 |
2013-11-26 |
Abbott Cardiovascular Systems Inc. |
Embolic filtering devices
|
WO2004108067A2
(en)
*
|
2003-04-03 |
2004-12-16 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
MXPA05010945A
(es)
*
|
2003-04-09 |
2005-11-25 |
Japan Tobacco Inc |
Compuesto pentaciclico heteroaromatico y uso medicinal del mismo.
|
US7820158B2
(en)
*
|
2003-04-10 |
2010-10-26 |
Surmodics, Inc. |
Ligand-coupled initiator polymers and methods of use
|
AU2004233693B2
(en)
*
|
2003-04-28 |
2007-07-19 |
Funahashi, Toru |
Adiponectin production enhancer
|
EP1618893A4
(en)
*
|
2003-04-28 |
2009-08-12 |
Sankyo Co |
MEANS FOR INCREASING SUGAR CAPACITY
|
US7230016B2
(en)
*
|
2003-05-13 |
2007-06-12 |
Synthon Ip Inc. |
Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
|
CN1812988A
(zh)
*
|
2003-05-13 |
2006-08-02 |
斯索恩有限公司 |
制备噻唑烷二酮衍生物的方法及其化合物
|
US20050004179A1
(en)
*
|
2003-05-22 |
2005-01-06 |
Pedersen Ward A. |
Methods and materials for treating, detecting, and reducing the risk of developing Alzheimer's Disease
|
JP2007506649A
(ja)
*
|
2003-06-27 |
2007-03-22 |
ドクター レディーズ リサーチ ファンデーション |
バラグリタゾンとさらなる抗糖尿病化合物とを含む組成物
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
US20070032404A1
(en)
*
|
2003-07-31 |
2007-02-08 |
Bayer Pharmaceuticals Corporation |
Methods for treating diabetes and related disorders using pde10a inhibitors
|
EP1510208A1
(en)
*
|
2003-08-22 |
2005-03-02 |
Fournier Laboratories Ireland Limited |
Pharmaceutical composition comprising a combination of metformin and statin
|
US20050054731A1
(en)
*
|
2003-09-08 |
2005-03-10 |
Franco Folli |
Multi-system therapy for diabetes, the metabolic syndrome and obesity
|
US7223761B2
(en)
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
JP2008500955A
(ja)
*
|
2003-10-27 |
2008-01-17 |
イノディア インコーポレイテッド |
糖尿病の治療に使用するための方法及び組成物
|
KR100952090B1
(ko)
|
2003-10-31 |
2010-04-13 |
다케다 야쿠힌 고교 가부시키가이샤 |
인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌소르비탄 지방산 에스테르를 함유하는 고체 제제
|
US7892251B1
(en)
|
2003-11-12 |
2011-02-22 |
Advanced Cardiovascular Systems, Inc. |
Component for delivering and locking a medical device to a guide wire
|
EP1841414A1
(en)
*
|
2003-12-31 |
2007-10-10 |
Alpharma, Inc. |
Rosiglitazone and metformin formulations
|
EP1732513A2
(en)
*
|
2003-12-31 |
2006-12-20 |
Alpharma, Inc. |
Rosiglitazone formulations
|
US7360069B2
(en)
*
|
2004-01-13 |
2008-04-15 |
Hewlett-Packard Development Company, L.P. |
Systems and methods for executing across at least one memory barrier employing speculative fills
|
TWI297606B
(en)
*
|
2004-01-16 |
2008-06-11 |
Nat Health Research Institutes |
Cancer therapy
|
WO2005074909A1
(ja)
*
|
2004-02-09 |
2005-08-18 |
Aska Pharmaceutical Co., Ltd. |
併用医薬
|
WO2005080387A2
(en)
*
|
2004-02-20 |
2005-09-01 |
Synthon B.V. |
Processes for making pioglitazone and compounds of the processes
|
US20070098778A1
(en)
*
|
2004-03-02 |
2007-05-03 |
Abeille Pharmaceuticals, Inc. |
Co-formulations or kits of bioactive agents
|
US7678129B1
(en)
|
2004-03-19 |
2010-03-16 |
Advanced Cardiovascular Systems, Inc. |
Locking component for an embolic filter assembly
|
US7161756B2
(en)
*
|
2004-05-10 |
2007-01-09 |
Tandberg Data Storage Asa |
Method and system for communication between a tape drive and an external device
|
CN1327840C
(zh)
*
|
2004-06-08 |
2007-07-25 |
天津药物研究院 |
一种药物组合物及其在制备用于治疗糖尿病中的应用
|
US20100048454A1
(en)
*
|
2004-08-03 |
2010-02-25 |
Emisphere Technologies, Inc. |
Antidiabetic oral insulin-biguanide combination
|
WO2006032011A2
(en)
*
|
2004-09-14 |
2006-03-23 |
Elixir Pharmaceuticals, Inc. |
Combination therapy for controlled carbohydrate digestion
|
MXPA04009236A
(es)
*
|
2004-09-23 |
2006-03-27 |
Jorge Luis Rosado Loria |
Composicion sinergistica para el tratamiento de diabetes y sus comorbilidades.
|
JP2008019169A
(ja)
*
|
2004-10-25 |
2008-01-31 |
Osaka Univ |
新規ppar調節剤およびそのスクリーニング方法
|
US20060089387A1
(en)
*
|
2004-10-26 |
2006-04-27 |
Le Huang |
Stabilized pharmaceutical composition comprising antidiabetic agent
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
US9259305B2
(en)
|
2005-03-31 |
2016-02-16 |
Abbott Cardiovascular Systems Inc. |
Guide wire locking mechanism for rapid exchange and other catheter systems
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
GT200600218A
(es)
*
|
2005-06-10 |
2007-03-28 |
|
Formulación y proceso de compresión directa
|
KR100964330B1
(ko)
*
|
2005-07-07 |
2010-06-17 |
학교법인 포항공과대학교 |
당흡수 조절제 및 당뇨병 또는 당뇨병 합병증의 치료방법
|
WO2007011524A1
(en)
*
|
2005-07-14 |
2007-01-25 |
Franco Folli |
Daily dosage regimen for treating diabetes, obsity, metabolic syndrome and polycystic ovary syndrome
|
JP4880685B2
(ja)
*
|
2005-07-22 |
2012-02-22 |
ザ プロクター アンド ギャンブル カンパニー |
薬物による不整脈の発生を低減するための組成物
|
MXPA05013220A
(es)
*
|
2005-12-06 |
2007-06-05 |
Leopoldo De Jesus Espinosa Abdala |
Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2.
|
GEP20115245B
(en)
|
2005-12-22 |
2011-06-27 |
Takeda Pharmaceutical |
Solid preparation
|
FR2896157B1
(fr)
|
2006-01-13 |
2008-09-12 |
Merck Sante Soc Par Actions Si |
Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.
|
WO2007105730A1
(ja)
*
|
2006-03-13 |
2007-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
インスリン抵抗性改善剤
|
AU2007227581B2
(en)
|
2006-03-16 |
2012-11-08 |
Metabolic Solutions Development Company, Llc |
Thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
|
US8338480B2
(en)
*
|
2006-03-31 |
2012-12-25 |
Wellstat Therapeutics Corporation |
Combination treatment of metabolic disorders
|
EA016715B1
(ru)
*
|
2006-04-11 |
2012-07-30 |
Сорбуотер Текнолоджи Ас |
Способ удаления веществ из потока жидкости
|
US7435741B2
(en)
|
2006-05-09 |
2008-10-14 |
Teva Pharmaceutical Industries, Ltd. |
2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
|
WO2008002591A2
(en)
|
2006-06-26 |
2008-01-03 |
Amgen Inc |
Methods for treating atherosclerosis
|
US7752724B2
(en)
*
|
2006-06-27 |
2010-07-13 |
Lumino, Inc. |
Method of cutting blinds
|
WO2008026668A1
(fr)
*
|
2006-08-31 |
2008-03-06 |
Daiichi Sankyo Company, Limited |
Composition médicale contenant un agent d'amélioration de la résistance à l'insuline
|
US20080182880A1
(en)
*
|
2006-09-28 |
2008-07-31 |
Mailatur Sivaraman Mohan |
Pioglitazone composition
|
US8217025B2
(en)
*
|
2006-11-17 |
2012-07-10 |
Harbor Therapeutics, Inc. |
Drug screening and treatment methods
|
US20080176905A1
(en)
*
|
2007-01-22 |
2008-07-24 |
Santiago Ini |
Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
|
JP5301465B2
(ja)
|
2007-01-25 |
2013-09-25 |
バーバ・ファーマシューティカルズ・リミテッド |
インスリン抵抗性改善薬および治療方法
|
UA95828C2
(ru)
*
|
2007-02-01 |
2011-09-12 |
Такеда Фармасьютикал Компани Лимитед |
Твердая рецептура, которая содержит алоглиптин и пиоглитазон
|
WO2008124122A1
(en)
*
|
2007-04-09 |
2008-10-16 |
Scidose, Llc |
Combinations of statins and anti-obesity agent and glitazones
|
US20160331729A9
(en)
|
2007-04-11 |
2016-11-17 |
Omeros Corporation |
Compositions and methods for prophylaxis and treatment of addictions
|
US11241420B2
(en)
|
2007-04-11 |
2022-02-08 |
Omeros Corporation |
Compositions and methods for prophylaxis and treatment of addictions
|
JP5548120B2
(ja)
|
2007-04-11 |
2014-07-16 |
オメロス コーポレーション |
嗜癖の予防および治療のための組成物および方法
|
US8216209B2
(en)
|
2007-05-31 |
2012-07-10 |
Abbott Cardiovascular Systems Inc. |
Method and apparatus for delivering an agent to a kidney
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
MX2009013293A
(es)
|
2007-06-04 |
2010-02-15 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
|
US7867273B2
(en)
|
2007-06-27 |
2011-01-11 |
Abbott Laboratories |
Endoprostheses for peripheral arteries and other body vessels
|
ES2449483T3
(es)
|
2007-07-26 |
2014-03-19 |
Amgen, Inc |
Enzimas lecitina-colesterol aciltransferasa modificadas
|
PL2203433T3
(pl)
*
|
2007-09-14 |
2013-04-30 |
Metabolic Solutions Dev Co Llc |
5-(4-(2-(3-metoksyfenylo)-2-oksoetoksy)benzylo)tiazolidyno-2,4-dion do stosowania w leczeniu cukrzycy
|
WO2009038107A1
(ja)
*
|
2007-09-21 |
2009-03-26 |
Kissei Pharmaceutical Co., Ltd. |
2型糖尿病治療用の組合せ医薬
|
WO2009073627A1
(en)
*
|
2007-11-30 |
2009-06-11 |
The Research Foundation Of State University Of New York |
Metabolic fuel switching biomarker
|
US8551524B2
(en)
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
WO2009120844A2
(en)
*
|
2008-03-26 |
2009-10-01 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical compositions comprising insulin sensitizer and insulin secretagogue
|
ES2627848T3
(es)
|
2008-06-04 |
2017-07-31 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
JP2011528375A
(ja)
|
2008-07-16 |
2011-11-17 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
US8846315B2
(en)
|
2008-08-12 |
2014-09-30 |
Zinfandel Pharmaceuticals, Inc. |
Disease risk factors and methods of use
|
BRPI0917948A2
(pt)
|
2008-08-12 |
2017-06-20 |
Zinfandel Pharrmaceuticals Inc |
métodos de identificar uma variante genética que está associada com o desenvolvimento de uma condição de interesse e um paciente em um ensaio clínico de um tratamento para doença de alzheimer, de determinar riscos incrementando de desenvolvimento de uma condição de interesse, doença de alzheimer em um paciente, de um prognóstico ou o risco de desenvolver doença de alzheimer em um paciente, de tratar um paciente para doença de alzheimer, uma condição de interesse e doença de alzheimer em um paciente, de estratificar um paciente em um subgrupo de um ensaio clínico de uma terapia para o tratamento de doença de alzheimer, uso de um agente ativo anti-doença de alzheimer e kits para determinar se um paciente encontra-se em risco incrementado de desenvolver doença de alzheimer e se um paciente é responsivo a tratamento para uma condição de interesse
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
CN106692144A
(zh)
|
2009-03-11 |
2017-05-24 |
奥默罗斯公司 |
预防和治疗成瘾的组合物和方法
|
US20110038848A1
(en)
|
2009-08-12 |
2011-02-17 |
Melaleuca, Inc. |
Dietary supplement compositions for cardiovascular health
|
TWI513462B
(zh)
|
2009-11-13 |
2015-12-21 |
Toray Industries |
糖尿病之治療或預防藥
|
RU2607453C2
(ru)
*
|
2009-12-04 |
2017-01-10 |
Сенхва Байосайенсиз, Инк. |
Пиразолопиримидины и родственные гетероциклы как ск2 ингибиторы
|
KR102029611B1
(ko)
*
|
2009-12-15 |
2019-10-07 |
씨리우스 테라퓨틱스, 엘엘씨 |
대사성 질환의 치료를 위한 ppar 절약형 티아졸리딘디온염
|
JP2013514368A
(ja)
*
|
2009-12-15 |
2013-04-25 |
メタボリック ソリューションズ ディベロップメント カンパニー, エルエルシー |
神経変性疾患を処置するための、ppar温存チアゾリジンジオンおよび組み合わせ物
|
EP2552442A1
(en)
|
2010-03-30 |
2013-02-06 |
Boehringer Ingelheim International GmbH |
Pharmaceutical composition comprising an sglt2 inhibitor and a ppar- gamma agonist and uses thereof
|
CA2795513A1
(en)
*
|
2010-04-06 |
2011-10-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
RU2526153C2
(ru)
*
|
2010-07-15 |
2014-08-20 |
Олег Ильич Эпштейн |
Способ повышения фармакологической активности действующего вещества лекарственного средства и фармацевтическая композиция
|
JP2013538807A
(ja)
|
2010-09-01 |
2013-10-17 |
ルピン・リミテッド |
メトホルミンおよびピオグリタゾンを含む医薬組成物
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
CN103221410B
(zh)
|
2010-09-22 |
2017-09-15 |
艾尼纳制药公司 |
Gpr119受体调节剂和对与其相关的障碍的治疗
|
CN107362165A
(zh)
|
2011-01-10 |
2017-11-21 |
金帆德尔制药股份有限公司 |
用于治疗阿尔茨海默病的方法和药物产品
|
WO2012100208A1
(en)
*
|
2011-01-20 |
2012-07-26 |
Bionevia Pharmaceuticals Inc. |
Modified release compositions of epalrestat or a derivative thereof and methods for using the same
|
WO2013034174A1
(en)
|
2011-09-06 |
2013-03-14 |
ZENTIVA Saglik Ürünleri Sanayi ve Ticaret A.S. |
Solid preparations of pioglitazone and glimepiride
|
US20130109671A1
(en)
|
2011-10-28 |
2013-05-02 |
Lumena Pharmaceuticals, Inc. |
Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases
|
MX368200B
(es)
|
2011-12-08 |
2019-09-24 |
Amgen Inc |
Proteinas de union al antigeno lecitin colesterol aciltransferasas humanas agonistas y su uso en terapia.
|
US20130158077A1
(en)
|
2011-12-19 |
2013-06-20 |
Ares Trading S.A. |
Pharmaceutical compositions
|
US9504679B2
(en)
|
2011-12-19 |
2016-11-29 |
Bjoern Colin Kahrs |
Pharmaceutical compositions comprising glitazones and Nrf2 activators
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
KR102272746B1
(ko)
|
2013-06-05 |
2021-07-08 |
보슈 헬스 아일랜드 리미티드 |
구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
|
JP2016534043A
(ja)
|
2013-10-09 |
2016-11-04 |
シナジー ファーマシューティカルズ インコーポレイテッド |
炎症促進性サイトカインのダウンレギュレーションに有用なグアニル酸シクラーゼのアゴニスト
|
RU2572706C1
(ru)
*
|
2014-06-30 |
2016-01-20 |
Олег Ильич Эпштейн |
Способ повышения фармакологической активности действующего вещества лекарственного средства и фармацевтическая композиция
|
JP7306791B2
(ja)
|
2015-02-06 |
2023-07-11 |
インターセプト ファーマシューティカルズ, インコーポレイテッド |
併用療法のための医薬組成物
|
IL285890B
(en)
|
2015-06-22 |
2022-07-01 |
Arena Pharm Inc |
Slate-free crystal of the arginine salt of (Ar)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-4,3,2,1-tetrahydro-cyclopent[b]indole-3-yl ) acetic acid
|
EP3568134A1
(en)
|
2017-01-16 |
2019-11-20 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Methods and pharmaceutical compositions for reducing cd95- mediated cell motility
|
CN117612666A
(zh)
|
2018-06-14 |
2024-02-27 |
阿斯利康(英国)有限公司 |
用二甲双胍药物组合物降低血糖的方法
|
CA3142358A1
(en)
|
2019-05-30 |
2020-12-03 |
Intercept Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease
|
CN112869173A
(zh)
*
|
2021-01-18 |
2021-06-01 |
广州富诺营养科技有限公司 |
一种复合维生素矿物质制剂及其制备方法
|